멜라토닌 시장(2026-2030년)

The global melatonin market is forecasted to grow by USD 1172666.8 thousand during 2025-2030, accelerating at a CAGR of 10.6% during the forecast period. The report on the global melatonin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness of sleep health, expanding availability through digital and retail channels, increasing demand for convenient wellness formulations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global melatonin market is segmented as below:

By Product

• Pharmaceutical grade melatonin
• Food grade melatonin

By Source

• Synthetic melatonin
• Natural melatonin

By Distribution Channel

• Offline
• Online

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • Turkey
  • South Africa
• Rest of World (ROW)

This study identifies the shift toward multifunctional sleep wellness products as one of the prime reasons driving the global melatonin market growth during the next few years. Also, expansion of premium and clean label positioning and rise of personalized sleep support approaches will lead to sizable demand in the market.

The report on the global melatonin market covers the following areas:

• Global melatonin market sizing
• Global melatonin market forecast
• Global melatonin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global melatonin market vendors that include Aspen Pharmacare Ltd., Aurobindo Pharma Ltd., Biotics Research Corp., Church and Dwight Co. Inc., CVS Health Corp., GNC Holdings LLC, Goli Nutrition Inc, Haleon Plc, Kenvue Inc., Life Extension, Natrol LLC, Nestle SA, Nordic Naturals Inc., NOW Health Group Inc., OLLY Public Benefit Corp., Perrigo Co. Plc, Pharmavite LLC, Procter and Gamble Co., Sanofi SA, Swanson Health Products Inc., Thorne HealthTech Inc., Walgreens Boots Alliance Inc., WN Pharmaceuticals Ltd.. Also, the global melatonin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Source
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Melatonin Market 2020 - 2024
  • Historic Market Size - Data Table on Global Melatonin Market 2020 - 2024 ($ thousand)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ thousand)
• 5.3 Source segment analysis 2020 - 2024
  • Historic Market Size - Source Segment 2020 - 2024 ($ thousand)
• 5.4 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on global melatonin market
• 6.2 Impact of geopolitical conflicts on global melatonin market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Pharmaceutical grade melatonin - Market size and forecast 2025-2030
• 8.4 Food grade melatonin - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ thousand)

9 Market Segmentation by Source

• 9.1 Market segments
• 9.2 Comparison by Source
• 9.3 Synthetic melatonin - Market size and forecast 2025-2030
• 9.4 Natural melatonin - Market size and forecast 2025-2030
• 9.5 Market opportunity by Source
  • Market opportunity by Source ($ thousand)

10 Market Segmentation by Distribution Channel

• 10.1 Market segments
• 10.2 Comparison by Distribution Channel
• 10.3 Offline - Market size and forecast 2025-2030
• 10.4 Online - Market size and forecast 2025-2030
• 10.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 Turkey - Market size and forecast 2025-2030
  • 12.7.4 South Africa - Market size and forecast 2025-2030
  • 12.7.5 Israel - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing awareness of sleep health
  • Expanding availability through digital and retail channels
  • Increasing demand for convenient wellness formulations
• 13.2 Market challenges
  • Regulatory complexity across regions
  • Raw material and supply chain vulnerabilities
  • Consumer confidence and product quality concerns
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward multifunctional sleep wellness products
  • Expansion of premium and clean label positioning
  • Rise of personalized sleep support approaches

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Aspen Pharmacare Ltd.
  • Aspen Pharmacare Ltd. - Overview
  • Aspen Pharmacare Ltd. - Business segments
  • Aspen Pharmacare Ltd. - Key offerings
  • Aspen Pharmacare Ltd. - Segment focus
  • SWOT
• 15.5 Church and Dwight Co. Inc.
  • Church and Dwight Co. Inc. - Overview
  • Church and Dwight Co. Inc. - Business segments
  • Church and Dwight Co. Inc. - Key offerings
  • Church and Dwight Co. Inc. - Segment focus
  • SWOT
• 15.6 CVS Health Corp.
  • CVS Health Corp. - Overview
  • CVS Health Corp. - Business segments
  • CVS Health Corp. - Key offerings
  • CVS Health Corp. - Segment focus
  • SWOT
• 15.7 GNC Holdings LLC
  • GNC Holdings LLC - Overview
  • GNC Holdings LLC - Product / Service
  • GNC Holdings LLC - Key offerings
  • SWOT
• 15.8 Kenvue Inc.
  • Kenvue Inc. - Overview
  • Kenvue Inc. - Business segments
  • Kenvue Inc. - Key news
  • Kenvue Inc. - Key offerings
  • Kenvue Inc. - Segment focus
  • SWOT
• 15.9 Life Extension
  • Life Extension - Overview
  • Life Extension - Product / Service
  • Life Extension - Key offerings
  • SWOT
• 15.10 Nestle SA
  • Nestle SA - Overview
  • Nestle SA - Business segments
  • Nestle SA - Key news
  • Nestle SA - Key offerings
  • Nestle SA - Segment focus
  • SWOT
• 15.11 Nordic Naturals Inc.
  • Nordic Naturals Inc. - Overview
  • Nordic Naturals Inc. - Product / Service
  • Nordic Naturals Inc. - Key offerings
  • SWOT
• 15.12 NOW Health Group Inc.
  • NOW Health Group Inc. - Overview
  • NOW Health Group Inc. - Product / Service
  • NOW Health Group Inc. - Key offerings
  • SWOT
• 15.13 Perrigo Co. Plc
  • Perrigo Co. Plc - Overview
  • Perrigo Co. Plc - Business segments
  • Perrigo Co. Plc - Key offerings
  • Perrigo Co. Plc - Segment focus
  • SWOT
• 15.14 Pharmavite LLC
  • Pharmavite LLC - Overview
  • Pharmavite LLC - Product / Service
  • Pharmavite LLC - Key offerings
  • SWOT
• 15.15 Procter and Gamble Co.
  • Procter and Gamble Co. - Overview
  • Procter and Gamble Co. - Business segments
  • Procter and Gamble Co. - Key news
  • Procter and Gamble Co. - Key offerings
  • Procter and Gamble Co. - Segment focus
  • SWOT
• 15.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.17 Thorne HealthTech Inc.
  • Thorne HealthTech Inc. - Overview
  • Thorne HealthTech Inc. - Product / Service
  • Thorne HealthTech Inc. - Key offerings
  • SWOT
• 15.18 Walgreens Boots Alliance Inc.
  • Walgreens Boots Alliance Inc. - Overview
  • Walgreens Boots Alliance Inc. - Product / Service
  • Walgreens Boots Alliance Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations